Makar Ralph 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Feb 1, 2011
Insider Transaction Report
Form 4
Makar Ralph
CEO/President
Transactions
- Exercise/Conversion
BJCT Common Stock
2011-01-30+50,000→ 877,368 total - Exercise/Conversion
Restricted Stock Unit
2011-01-30−50,000→ 50,000 totalFrom: 2011-01-30→ BJCT Common Stock (50,000 underlying)
Holdings
- 142,322(indirect: By 401(k))
BJCT Common Stock
Footnotes (3)
- [F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
- [F3]No expiration date.